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Molluscum contagiosum virus (MCV) is a common pathogen causing a troublesome skin condition in many immunocompe-
tent individuals and a widespread, disfiguring affliction in many patients with AIDS. We have successfully infected human
foreskin fragments with a patient-derived isolate of MCV. This was demonstrated by exposing the foreskin pieces to a
patient lesion extract and implanting the tissue under the renal capsule of athymic mice. Light and electron microscopic
examination of infected implants showed the presence of cytoplasmic inclusions containing typical poxvirus particles within
2 – 3 weeks of implantation. Replication of MCV was established by demonstrating that viable virus was required to produce
the cytopathologic effects, and viral DNA replication was demonstrated by incorporation of bromodeoxyuridine into cyto-
plasmic inclusions. Four additional patient extracts (representing both described MCV types) were also used to successfully
infect foreskin implants. A limited number of attempts to pass virus from one infected implant to another were not successful.
This system is the most rapid and reproducible for growing MCV that has been reported to date. q 1996 Academic Press, Inc.
INTRODUCTION date, no other laboratory growth system for MCV has
been reported.
Molluscum contagiosum virus (MCV) is a member of The clinical disease caused by MCV is considered a
the family Poxviridae and has been tentatively assigned common, but minor cutaneous infection of children and
its own genus, Molluscipoxvirus, which is distinct from a relatively frequent sexually transmitted disease among
the better known Orthopoxvirus members such as variola young adults. Infection leads to discrete, skin-colored,
and vaccinia. As is typical of this family, the virion is white or pearly papular lesions with a characteristic um-
large (200–400 nm) and has a complex structure. The bilicated center. The soft lesion center can be removed
virus has a linear DNA genome of 190,289 bp (Parr et by curettage and consists a 0.1- to 0.3-mm sphere that
al., 1977; Senkevich et al., 1996) which contains a mini- is largely acellular but contains large quantities of virus.
mum of 163 potential open reading frames. Two major Histologically, there is lobular hyperplasia of the epithe-
genotypes of MCV have been identified based on restric- lium. The virus does not cause obvious changes in the
tion endonuclease cleavage patterns of viral DNA (Darai basal layer of the epithelium, but adjacent layers of kera-
et al., 1986; Porter et al., 1989, 1987) and several variants tinocytes become enlarged and granular. There are intra-
have also been reported (Bugert and Darai, 1991). A third cytoplasmic inclusions which displace the nucleus and
genotype has been proposed, but there is no convention eventually flatten the nucleus against the cell membrane.
for distinguishing genotypes from variants (Porter and In both children and adults, the disease is typically a
Archard, 1992). There is no described serotyping system self-limited infection that will resolve without treatment
for MCV, so types cannot be distinguished by traditional in a period of months, occasionally lasting for more than
virologic methods. MCV grows in cutaneous epithelium 1 year. Treatment is usually undertaken for cosmetic rea-
and forms large, cytoplasmic inclusions which are typical sons or to reduce the probability of spread of the infection
of poxviruses (Reed and Parkinson, 1977). Although MCV to others. Only if the lesion is located in a critical area
is pathogenic for humans, the virus has not been grown which interferes with function, such as the eyelid, is treat-
successfully in human or animal cell culture (Pirie et ment mandated (Charteris et al., 1995). The lesions can
al., 1971; Shand et al., 1976). In one recent report, MCV be treated with ablative therapy, but recurrence is
infection was achieved by engrafting human skin onto common.
immunodeficient mice and exposing the skin to an ex- In contrast, MCV-induced lesions which occur in pa-
tract derived from a patient lesion (Buller et al., 1995). To tients infected with the human immunodeficiency virus
can become extensive and refractory to therapy, espe-
cially in patients with severe immunosuppression (Gott-1 To whom correspondence and reprint requests should be ad-
lieb and Myskowski, 1994; Schwartz and Myskowski,dressed at 545 Barnhill Drive, Emerson Hall 435, Indianapolis, IN 46202-
5124. Fax: (317) 274-1587; E-mail: fife@infect.dmed.iupui.edu. 1992; Smith et al., 1994). MCV infections are seen in up
95
0042-6822/96 $18.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
AID VY 8275 / 6a25$$$341 11-01-96 13:48:31 viral AP: Virology
96 FIFE ET AL.
to 20% of AIDS patients making them one of the most mice were given bromodeoxyuridine (BrdU) (50 mg/kg
in sterile phosphate-buffered saline) by intraperitonealcommon skin disorders of AIDS (Ray and Gately, 1994).
Although the MCV lesions rarely lead to life-threatening injection 24–48 hr prior to sacrifice. The implants were
removed, photographed, and either fixed for microscopysituations in AIDS patients, they can lead to severe disfig-
urement and may adversely affect the afflicted individu- or frozen.
al’s quality of life. Ablative therapy is impractical in pa-
Light and electron microscopytients with extensive disease, but no other effective ther-
apy is currently available. In addition, the surrounding, Patient specimens or foreskin implants were fixed in
normal-appearing skin has been shown to contain virus 10% buffered formalin for light microscopy or 3% glutaral-
as well, an observation which probably accounts for the dehyde for electron microscopy. The tissue was embed-
high relapse rate (Smith et al., 1992). Although a complex ded and sectioned. The formalin-fixed sections were
virus like MCV would be an excellent target for selective stained with hematoxylin and eosin and the glutaralde-
antiviral therapy, no effective anti-MCV drugs have been hyde-fixed sections were stained with uranyl acetate.
developed to date. Much of the reason for the lack of
therapeutic agents is due to the lack of a convenient Immunostaining for BrdU
culture system for the virus in which potential antivirals
The immunostaining was performed as describedcan be tested. In this communication, we report the de-
(Schutte et al., 1987b; Ubink et al., 1995). Briefly, implantsvelopment of a system for the predictable laboratory
from BrdU-treated mice were fixed in 4% paraformalde-growth of MCV.
hyde (Schutte et al., 1987a). Unstained sections were
deparaffinized and digested with pepsin in 0.1 N HCl.MATERIALS AND METHODS
DNA was denatured by treatment with 2 N HCl and the
Clinical material sections were washed and incubated with a mouse
monoclonal antibody to BrdU (obtained from Dako Corp.,Specimens were collected from patients who were be-
Carpinteria, CA) overnight. Antibody binding was de-ing treated for multiple molluscum contagiosum lesions
tected using a Vectastain ABC kit (Dako Corporation) forby curettage. The extracted contents (‘‘centers’’) of the
immunoperoxidase staining of bound mouse monoclonalMCV lesions were saved on moistened gauze and trans-
antibodies.ported to the laboratory. MCV lesion centers were placed
in screw-capped tubes and frozen at 0707 or fixed in
DNA extractionbuffered formalin or glutaraldehyde for microscopic ex-
amination. MCV lesion centers were minced with a scalpel blade
and incubated overnight in a solution containing prote-
Preparation of infectious extracts ase K (200 mg/ml) and 1% SDS. The mixture was then
extracted with phenol and chloroform:isoamyl alcoholExtracts were made using several MCV lesion centers
(24:1) and the DNA was precipitated with ethanol.which had been curetted from individual patients with
multiple lesions. Tissue from each patient was thawed
Restriction endonuclease digestionand homogenized with a Teflon pestle in a small conical
tube, and a suspension was made in Eagle’s minimal Extracted MCV DNA was digested with BamHI or Hin-
essential medium (MEM). dIII (obtained from GIBCO/BRL, Gaithersburg, MD) ac-
cording to the supplier’s directions. Digested DNA was
Infection of foreskin fragments and implantation into loaded onto a 0.7% agarose gel and bands were visual-
mice ized by staining with ethidium bromide.
The dermis was removed from the epidermis of a
RESULTSfreshly acquired human newborn foreskin. The epidermis
was then ‘‘wounded’’ with a 25-gauge needle and cut into Early kinetics of growth in the model system
fragments and placed in MEM containing penicillin and
streptomycin. An aliquot of each MCV lesion extract (or To characterize the system and establish the ability of
MCV to replicate in this model system, an extract wasMEM control) was added to separate tubes containing
foreskin fragments and incubated for 90 min at 377. made from lesions removed from a patient infected with
MCV type 1. The typing was based on restriction endonu-Athymic mice (nu/nu on a Balb/c background) were anes-
thetized and the kidneys exposed through dorsolateral clease digestion of viral DNA (data not shown). The ex-
tract was used to infect pieces of fresh, normal newbornincisions. A fragment of infected foreskin tissue (approxi-
mately 1 1 1 1 1 mm) was slipped under the renal human foreskin as described under Materials and Meth-
ods. The foreskin fragments were then implanted undercapsule with forceps. The incisions were closed and the
mice were observed for various times (between 10 and the renal capsule of athymic mice. Infected foreskin im-
plants were removed and examined at approximately 10-126 days) and then sacrificed. In some experiments, the
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TABLE 1 MCV-infected and uninfected implants, but these could
not be reproducibly identified on blinded examination ofEarly Time Course and Inactivation of MCV
implant photographs.
Size Histologic examination of the implants showed some
Specimen Day (mm)a Histologyb EMc evidence of infection as early as 11 days after placement
in mice. By 32 days, there were extensive histologic
Active extract 11 1 1 1 eq NDd
changes (Figs. 1A and 1B) showing multiple foci of epi-20 2 1 2 0 ND
thelial proliferation containing cells with large, cyto-32 2.1 1 2.5 / /
41 1.8 1 2.5 / ND plasmic, eosinophilic inclusions. Similar changes were
UV inactivated extract 11 1 1 1.5 0 ND also seen in the 41-day implants. Implants that were not
20 1 1 1.5 0 ND exposed to the MCV-containing extract showed histologi-
32 3 1 3 0 0
cally normal epithelium at all times examined (Fig. 1C,41 2.5 1 3.5 0 ND
Table 1).Uninfected control implant 11 1.5 1 1.75 0 ND
20 1. 1 1.5 0 ND Electron microscopic examination of some the MCV-
32 1.5 1 2 0 ND infected implants showed multiple large cytoplasmic in-
41 2 1 2.75 0 ND clusions containing typical 150 1 1001 300-nm poxvirus
particles (Figs. 2A and 2B). These particles are indistin-a Measurement is length by width; value is an average of two to four
guishable from those reported in patient lesions by Mid-implants at each time point.
b A positive histology implies identification of at least one definite dlekamp and Munger (1964). Also seen on electron mi-
focus of abnormal cells containing cytoplasmic inclusions in the cuta- croscopy were immature and maturing poxvirus particles
neous epithelium of the implant; the designation eq (equivocal) implies (Fig. 2C) which are typical of those described for MCV
that enlarged cells with possible cytoplasmic inclusions were seen, but
(Middelkamp and Munger, 1964) and other poxviruses.distinct foci of involvement were not identified; (0) implies histologically
normal epithelium.
Evidence for viral replicationc Electron microscopy: a positive result implies visualization of char-
acteristic poxviral particles.
Although highly suspicious histologic changes wered ND, not done.
seen by light microscopy and typical mature and imma-
ture viral particles were seen by electron microscopy,
these observations do not unequivocally demonstrateday intervals for 40 days. The results of this experiment
are summarized in Table 1. The MCV-infected implants replication of the virus. To demonstrate active replication,
we performed a parallel experiment in which foreskinslowly increased in size during the course of the experi-
ment, but the growth was not significantly greater than tissue was incubated with the same MCV-containing pa-
tient lesion extract used in the experiments describedthat of uninfected foreskin implants. There appeared to
be subtle differences in gross appearance between above; however, the extract had been pretreated with 50
FIG. 1. Histologic appearance of the foreskin implants. A shows a low-power view of a 32-day MCV-infected implant demonstrating the human
epithelial cyst surrounded fibrous tissue. The center of the cyst contains desquamated keratinized epithelium. The arrows show multiple foci of
MCV infection around the circumference of the cyst (original magnification 401). B shows a higher power view of one of the more heavily involved
regions. There are multiple enlarged epithelial cells with cytoplasmic inclusions (original magnification 1001). C shows an uninfected foreskin
implant also at 32 days. The epithelium is well ordered and the thickness is relatively uniform. No inclusions are seen (original magnification 1001).
The stain is hematoxylin and eosin for A, B, and C.
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FIG. 2. Electron microscopic appearance of foreskin implants at 21 days. A shows a low-power view of an inclusion showing viral particles as
well as melanin pigment granules. B shows a higher power view demonstrating the obvious hourglass-shaped, electron-dense nucleoid in several
virions. C shows immature, spherical viral particles (arrows) and particles with oval, immature cores (arrowheads) in addition to mature virions.
The bar in A is 1000 nm and in B it is 500 nm; in C, the arrows are 200 nm.
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mice for as long as 126 days. Surprisingly, while implants
removed at 42 days or earlier showed comparable MCV-
induced histologic changes in all cases, implants left in
the mice for 84 days or longer appeared histologically
normal. The implants that had been exposed to MCV-
containing extracts tended to become more enlarged
than control implants after prolonged times in the mouse
(see Table 2) but there was no difference in the micro-
scopic appearance of the epithelium between infected
and control implants at 84 or 126 days.
Passage of virus to fresh implants
To determine if the virus produced in the foreskin im-
plants is infectious, extracts were made from two MCV
type 1-infected implants and these extracts were used
to infect fresh foreskin fragments. The implants used to
make the extracts were known to have histologic
changes suggestive of MCV infection by light or electron
microscopy. The results of the passage experiments are
shown in Table 2. There was no evidence of MCV growth
FIG. 2—Continued
J/m2 of ultraviolet irradiation. This dose of ultraviolet light
has been shown to inactivate vaccinia virus (Grunwald-
Beard et al., 1991), and would be expected to inactivate
MCV as well. These implants showed only histologically
normal epithelium at all time points (Table 1). Electron
microscopy of an implant exposed to UV-irradiated virus
removed at 32 days showed no evidence of viral parti-
cles.
To provide further evidence for active viral replication,
implants from animals treated with 50 mg/kg BrdU prior
to sacrifice were examined by immunohistochemistry us-
ing a monoclonal antibody to BrdU. The results are
shown in Fig. 3. A number of the cytoplasmic inclusions
are seen in the implant which stained with the anti-BrdU
antibody, suggesting that active cytoplasmic DNA syn-
thesis was taking place during the time of BrdU expo-
sure. BrdU staining of nuclei was seen only in occasional
suprabasal cells.
Infection of implants with different MCV strains and
types
To determine if other patient isolates and both MCV
types could be grown in this model system, extracts from
four other patients (two containing MCV type 1 and two FIG. 3. Incorporation of BrdU into cytoplasmic inclusions. Additional
sections of the same implant shown in Fig. 1 were made. A shows acontaining MCV type 2) were made and were used to
section stained with hematoxylin and eosin. B shows a similar (but notinfect foreskin fragments. The results are shown in Table
contiguous) section stained with a monoclonal antibody to BrdU and2. In addition to evaluating more MCV strains, we also
detected by immunoperoxidase staining. Note the staining of some
sought to determine if the MCV infection would cause cytoplasmic inclusions (arrows on the left) as well as occasional su-
the implants to continue to proliferate and produce more prabasal nuclei (arrowheads on the lower left). Original magnification
was 2001 for both A and B.virus. In these experiments, implants were left in the
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at early or late times after implantation by either light or The recent report of the complete nucleotide sequence
of the MCV 1 genome (Senkevich et al., 1996) shouldelectron microscopy.
make some functional studies of subgenomic fragments
of MCV DNA more feasible.DISCUSSION
The challenge of growing viruses which appear to re-
MCV is a highly prevalent human pathogen. It is known quire factors or conditions difficult to reproduce in culture
to cause a relatively mild, but bothersome, disease in can be daunting. Even using primary cells of a type
immunocompetent persons. In immunocompromised pa- known to support growth of the virus in vivo may not be
tients, especially persons with AIDS, the disease can successful because of changes induced in the cells by
be more aggressive and disfiguring. In the absence of placing them in culture. Human tissue xenografts in im-
accurate diagnostic tests, the full spectrum of MCV-in- munodeficient mice have been used to propagate sev-
duced disease may not be defined. Investigation of this eral human and animal papillomaviruses which have de-
agent has been hampered by the lack of an in vitro propa- fied growth in simpler culture systems (Kreider et al.,
gation system. Because the genome is so large, it has 1987, 1985). The same laboratory recently reported grow-
not been possible to readily circumvent some of the prob- ing MCV on human foreskin grafts on the surface of
lems of the lack of a propagation system by cloning the athymic mice (Buller et al., 1995). While successful, that
full-length viral genome, as has been done for pathogens system is quite inefficient because many grafts were
such as the human papillomaviruses and hepatitis C vi- rejected and the MCV infection rate of the surviving grafts
rus. Although nearly all segments of MCV DNA have was only about 50%. It is not clear if infection with more
been cloned (Bugert and Darai, 1991; Darai et al., 1986), than one MCV isolate was attempted, but the reported
functional studies of the virus have not been reported. successful growth was from only a single patient isolate.
We were able to grow every isolate we attempted which
consisted of five different patient isolates, representing
TABLE 2
both MCV types.
Summary of Foreskin Xenograft Implant Results Our experiments demonstrate unequivocal replication
with Different Inocula of MCV in this model system. The immature viral particles
seen by electron microscopy provide strong evidence ofMCV Size
active viral growth. All morphologic stages from the verySpecimen type Day (mm)a Histologyb EMc
early, spherical forms to the fully mature particles with
1 1 21 1 1 1.5 / / condensed nucleoid cores could be identified by electron
42 1.5 1 1.5 / NDd microscopy. In addition, the amount of BrdU incorpora-
2 1 42 1.5 1 1.5 / ND
tion into the cytoplasmic inclusions can only be ex-84 2 1 2 0 ND
plained by viral DNA replication. Furthermore, Fig. 2A126 2 1 2 0 ND
3 2 42 2.5 1 2 / ND provides evidence that it is the foreskin epithelial cells
84 3 1 2.5 0 ND that are infected because the ‘‘donor’’ of the virus inocu-
4 2 42 1 1 1.5 / / lum was Caucasian while foreskin ‘‘donor’’ was African-
126 4 1 4 0 ND
American and the number of melanin pigment granules
Passage of specimen 1e 1 28 1 1 1 0 ND seen in the infected cell is consistent with a cell from an
42 1.5 1 1.5 0 ND African-American.
84 3 1 3 0 0
It was anticipated that the ability to propagate MCV inPassage of specimen 2 f 1 42 2.5 1 1 0 ND
this model system would permit the production of largeControl (uninfected) — 126 1.5 1 1.5 0 ND
quantities of a well-characterized stock of virus. Unfortu-
a Measurement is length by width; value is an average of two to four nately, it appears that the virus proceeds through the
implants at each time point; in general, implants ⁄42 days old were epithelium over the period of 4–6 weeks but then does
roughly spherical.
not reinfect other cells in the implant. This aspect pre-b A positive histology implies identification of at least one definite
vents significant amplification of virus. It is interestingfocus of abnormal cells containing cytoplasmic inclusions in the cuta-
neous epithelium of the implant; (0) implies normal histology. that the implants appear to continue to increase in size
c Electron microscopy: a positive result implies visualization of char- compared to uninfected implants even after all evidence
acteristic poxiviral particles. of viral replication has vanished. The reason for this con-d ND, not done.
tinued growth is unclear, but there is a definite differencee This section represents two separate experiments, one in which
between infected and control (uninfected) implants withimplants were left in 4 or 6 weeks prior to sacrifice and another in
which implants were left in for 12 weeks. In each case, the 21- and respect to growth rate.
42-day implants from specimen 1 were pooled to make the inoculum. We were not able to unequivocally demonstrate pas-
All other sections of the table represent single experiments in which sage of virus from one implant to another. However, only
a single foreskin was infected with a lesion extract and one or two
two serious attempts at propagation were made. Im-animals were sacrificed at the times indicated.
plants which had been exposed to extracts from previousf The 42-day implant from specimen 2 was used to make the inocu-
lum for this experiment. implants grew to somewhat larger sizes than control im-
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ber, J. A. (1987). Laboratory production in vivo of infectious humanplants, but we were unable to locate histologic evidence
papillomavirus type 11. J. Virol. 61, 590–593.of MCV infection. This suggests that either the passage
Kreider, J. W., Howlett, M. K., Wolfe, S. A., Bartlett, G. L., Zaino, R. J.,
implants were infected with MCV at a level too low to Sedlacek, T. V., and Mortel, R. (1985). Morphological transformation
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Middelkamp, J. N., and Munger, B. L. (1964). The ultrastructure andstimulated growth by some other mechanism. The inabil-
histogenesis of molluscum contagiosum. J. Pediatr. 64, 888–905.ity to infect secondary implants plus the apparent inability Parr, R. P., Burnett, J. W., and Garon, C. F. (1977). Ultrastructural charac-
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Pirie, G. D., Bishop, P. M., Burke, D. C., and Postlethwaite, R. (1971).produced in this model is noninfectious. Although the
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Virol. 13, 311–320.
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